In silico analysis and validation of the cancer-associated fibroblasts-related gene CAMK4 promotes bladder cancer progression
- 1Department of Urology, Jingzhou Hospital Affiliated to Yangtze University
Abstract
Cancer-associated fibroblasts (CAFs) play an integral role in modulating the biological behavior of cancer cells through intricate and dynamic communication networks. However, the specific mechanism by which CAFs influence bladder cancer (BCa) remains elusive. This study integrated transcriptome data from multiple datasets to construct a gene ensemble associated with CAFs using a series of computational algorithms. This analysis identified two distinct molecular subtypes of BCa, characterized by varying levels of immune cell infiltration and immune-related features. CAMK4 was subsequently selected for further validation, revealing its role in enhancing the tumor-promoting functions of BCa, particularly in terms of proliferation, migration, invasion, and the induction of epithelial-mesenchymal transition (EMT). To sum up, the identified signature and its corresponding subtypes enable the identification of potential candidates for immunotherapy among BCa patients. Additionally, CAMK4 may emerge as a promising therapeutic target for BCa treatment.
Related
- FLNA Expression in Cancer-Associated Fibroblasts Is Associated with Immunosuppression and Tumor Progression in Colorectal Cancer.
- Spondin 1 Enriched in p16Ink4a Reporter-Labeled Fibroblasts Promotes Melanoma Cell Proliferation in Vitro and Is Associated with Poor Prognosis
- ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression
- JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway
- Leptin promotes obesity‑related osteoarthritis progression via CD44/JAK2/STAT3 axis‑mediated chondrocyte apoptosis.
BibTeX
@article{su2026silico,
title = {{In silico analysis and validation of the cancer-associated fibroblasts-related gene CAMK4 promotes bladder cancer progression}},
author = {Xiaokang Su and Yi Guo and Youkong Li},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-60370-8},
url = {https://doi.org/10.1038/s41598-026-60370-8},
note = {CC BY},
}
RIS
TY - JOUR
TI - In silico analysis and validation of the cancer-associated fibroblasts-related gene CAMK4 promotes bladder cancer progression
AU - Xiaokang Su
AU - Yi Guo
AU - Youkong Li
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-60370-8
UR - https://doi.org/10.1038/s41598-026-60370-8
AB - Cancer-associated fibroblasts (CAFs) play an integral role in modulating the biological behavior of cancer cells through intricate and dynamic communication networks. However, the specific mechanism by which CAFs influence bladder cancer (BCa) remains elusive. This study integrated transcriptome data from multiple datasets to construct a gene ensemble associated with CAFs using a series of computational algorithms. This analysis identified two distinct molecular subtypes of BCa, characterized by varying levels of immune cell infiltration and immune-related features. CAMK4 was subsequently selected for further validation, revealing its role in enhancing the tumor-promoting functions of BCa, particularly in terms of proliferation, migration, invasion, and the induction of epithelial-mesenchymal transition (EMT). To sum up, the identified signature and its corresponding subtypes enable the identification of potential candidates for immunotherapy among BCa patients. Additionally, CAMK4 may emerge as a promising therapeutic target for BCa treatment.
SN - 2045-2322
ER -